Home » Newsletters » BioWorld Science

BioWorld Science

March 15, 2006

View Archived Issues

PRX-00023 safe, induces prolactin release in healthy subjects

Rotigaptide safe, demonstrates predictable pharmacokinetics in healthy subjects

Sanochemia reports PVP-Hypericin progress

ACE BioSciences and Nordic Vaccine collaborate on vaccine development

Tetracyclines in dental research

Targeted chemotherapy with AN-215 in experimental prostate cancers yields positive results

Blockade of EGFR and IL-13 ceases progression towards asthma/bronchitis phenotype in mice

Efficacy and tolerability of fast-acting degarelix shown in patients with prostate cancer

Significant neutropenia seen with lenalidomide/docetaxel in patients with advanced solid tumors

Irinotecan drug-eluting beads studied for colorectal cancer metastases in the liver

Phase I/II study of L-annamycin for relapsed/refractory ALL adds new trial site

CytRx provides overview of recent developments in obesity and type 2 diabetes

Ad.SERCA2a gene therapy improves cardiac function in a large animal model of heart failure

Iomai receives award for pandemic flu research

Hana completes development of Zensana

Positive follow-up data from Multikine phase II study in head and neck cancer

FDA Advisory Committee votes against approval of Gemzar for ovarian cancer

Merck KGaA makes offer for Schering AG

Watson to acquire Andrx

FDA to consult Advisory Committee on proposed RESUS trial of Hemopure

ISIS-301012 does not interact with simvastatin or ezetimibe in study

AT-1001 completes phase Ib in celiac disease patients

Generic name pafuramidine maleate approved for Immtech's DB-289

BioMS to study MBP-8298 for relapsing-remitting MS

Long-term treatment benefits of Flurizan

Lipid subfractions, timing of doses studied with torcetrapib

TG-100-115 appears safe in STEMI patients undergoing PCI

Fast track designation for PPI-0903

XenoPort initiates phase III for XP-13512 in RLS

Surface Logix begins phase I study for SLx-4090

Efficacy of GW-685698 in seasonal allergic rhinitis reported

Neurotech reports promising results of phase I NT-501 safety trial

Recent patents report novel agents for pain, migraine, etc.

Novel antiinfective agents disclosed in recent patent literature

Novel agents with potential for treatment of inflammatory disorders revealed in recent patents

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...